Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

NUTX vs CYH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NUTX
Nutex Health, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$801M
5Y Perf.-90.5%
CYH
Community Health Systems, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$408M
5Y Perf.-62.3%

NUTX vs CYH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NUTX logoNUTX
CYH logoCYH
IndustryMedical - Healthcare Information ServicesMedical - Care Facilities
Market Cap$801M$408M
Revenue (TTM)$880M$21.48B
Net Income (TTM)$96M$-88M
Gross Margin47.5%53.7%
Operating Margin31.4%-39.8%
Forward P/E8.7x0.8x
Total Debt$351M$11.58B
Cash & Equiv.$186M$260M

NUTX vs CYHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NUTX
CYH
StockApr 22May 26Return
Nutex Health, Inc. (NUTX)1009.5-90.5%
Community Health Sy… (CYH)10037.7-62.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: NUTX vs CYH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NUTX leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Community Health Systems, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
NUTX
Nutex Health, Inc.
The Growth Play

NUTX carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 82.4%, EPS growth 7.9%, 3Y rev CAGR 58.6%
  • 82.4% revenue growth vs CYH's -1.2%
  • 11.0% margin vs CYH's -0.4%
Best for: growth exposure
CYH
Community Health Systems, Inc.
The Income Pick

CYH is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 2 yrs, beta 1.60
  • -80.3% 10Y total return vs NUTX's -97.8%
  • Lower volatility, beta 1.60, current ratio 1.46x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthNUTX logoNUTX82.4% revenue growth vs CYH's -1.2%
ValueCYH logoCYHLower P/E (0.8x vs 8.7x)
Quality / MarginsNUTX logoNUTX11.0% margin vs CYH's -0.4%
Stability / SafetyCYH logoCYHBeta 1.60 vs NUTX's 2.01
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)NUTX logoNUTX+14.6% vs CYH's -11.7%
Efficiency (ROA)NUTX logoNUTX10.5% ROA vs CYH's -0.7%, ROIC 38.0% vs -70.1%

NUTX vs CYH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NUTXNutex Health, Inc.
FY 2024
Hospital Division
100.0%$449M
CYHCommunity Health Systems, Inc.
FY 2025
Managed Care And Other Third Party Payors
58.4%$6.0B
Medicare
21.2%$2.2B
Medicaid
19.5%$2.0B
Self Pay Revenue
0.9%$96M

NUTX vs CYH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNUTXLAGGINGCYH

Income & Cash Flow (Last 12 Months)

NUTX leads this category, winning 4 of 6 comparable metrics.

CYH is the larger business by revenue, generating $21.5B annually — 24.4x NUTX's $880M. NUTX is the more profitable business, keeping 11.0% of every revenue dollar as net income compared to CYH's -0.4%.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …
RevenueTrailing 12 months$880M$21.5B
EBITDAEarnings before interest/tax$297M-$7.8B
Net IncomeAfter-tax profit$96M-$88M
Free Cash FlowCash after capex$270M-$200M
Gross MarginGross profit ÷ Revenue+47.5%+53.7%
Operating MarginEBIT ÷ Revenue+31.4%-39.8%
Net MarginNet income ÷ Revenue+11.0%-0.4%
FCF MarginFCF ÷ Revenue+30.7%-0.9%
Rev. Growth (YoY)Latest quarter vs prior year+2.2%+2.8%
EPS Growth (YoY)Latest quarter vs prior year+154.7%-45.2%
NUTX leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CYH leads this category, winning 3 of 3 comparable metrics.

At 0.8x trailing earnings, CYH trades at a 94% valuation discount to NUTX's 12.8x P/E.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …
Market CapShares × price$801M$408M
Enterprise ValueMkt cap + debt − cash$967M$11.7B
Trailing P/EPrice ÷ TTM EPS12.84x0.77x
Forward P/EPrice ÷ next-FY EPS est.8.73x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple3.27x
Price / SalesMarket cap ÷ Revenue0.92x0.03x
Price / BookPrice ÷ Book value/share2.15x
Price / FCFMarket cap ÷ FCF3.26x1.96x
CYH leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

NUTX leads this category, winning 7 of 7 comparable metrics.

On the Piotroski fundamental quality scale (0–9), NUTX scores 7/9 vs CYH's 6/9, reflecting strong financial health.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …
ROE (TTM)Return on equity+22.2%
ROA (TTM)Return on assets+10.5%-0.7%
ROICReturn on invested capital+38.0%-70.1%
ROCEReturn on capital employed+43.2%-87.3%
Piotroski ScoreFundamental quality 0–976
Debt / EquityFinancial leverage0.83x
Net DebtTotal debt minus cash$166M$11.3B
Cash & Equiv.Liquid assets$186M$260M
Total DebtShort + long-term debt$351M$11.6B
Interest CoverageEBIT ÷ Interest expense9.13x4.89x
NUTX leads this category, winning 7 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — NUTX and CYH each lead in 3 of 6 comparable metrics.

A $10,000 investment in CYH five years ago would be worth $1,902 today (with dividends reinvested), compared to $224 for NUTX. Over the past 12 months, NUTX leads with a +14.6% total return vs CYH's -11.7%. The 3-year compound annual growth rate (CAGR) favors NUTX at 20.5% vs CYH's -6.0% — a key indicator of consistent wealth creation.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …
YTD ReturnYear-to-date-9.2%-6.6%
1-Year ReturnPast 12 months+14.6%-11.7%
3-Year ReturnCumulative with dividends+74.8%-16.8%
5-Year ReturnCumulative with dividends-97.8%-81.0%
10-Year ReturnCumulative with dividends-97.8%-80.3%
CAGR (3Y)Annualised 3-year return+20.5%-6.0%
Evenly matched — NUTX and CYH each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NUTX and CYH each lead in 1 of 2 comparable metrics.

CYH is the less volatile stock with a 1.60 beta — it tends to amplify market swings less than NUTX's 2.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NUTX currently trades 69.7% from its 52-week high vs CYH's 64.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …
Beta (5Y)Sensitivity to S&P 5002.01x1.60x
52-Week HighHighest price in past year$193.07$4.47
52-Week LowLowest price in past year$77.21$2.38
% of 52W HighCurrent price vs 52-week peak+69.7%+64.8%
RSI (14)Momentum oscillator 0–10059.746.4
Avg Volume (50D)Average daily shares traded197K1.6M
Evenly matched — NUTX and CYH each lead in 1 of 2 comparable metrics.

Analyst Outlook

CYH leads this category, winning 1 of 1 comparable metric.

Wall Street rates NUTX as "Buy" and CYH as "Hold". Consensus price targets imply 52.3% upside for NUTX (target: $205) vs 1.2% for CYH (target: $3).

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$205.00$2.93
# AnalystsCovering analysts237
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises12
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+0.6%+0.5%
CYH leads this category, winning 1 of 1 comparable metric.
Key Takeaway

NUTX leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CYH leads in 2 (Valuation Metrics, Analyst Outlook). 2 tied.

Best OverallNutex Health, Inc. (NUTX)Leads 2 of 6 categories
Loading custom metrics...

NUTX vs CYH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is NUTX or CYH a better buy right now?

For growth investors, Nutex Health, Inc.

(NUTX) is the stronger pick with 82. 4% revenue growth year-over-year, versus -1. 2% for Community Health Systems, Inc. (CYH). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate Nutex Health, Inc. (NUTX) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NUTX or CYH?

On trailing P/E, Community Health Systems, Inc.

(CYH) is the cheapest at 0. 8x versus Nutex Health, Inc. at 12. 8x.

03

Which is the better long-term investment — NUTX or CYH?

Over the past 5 years, Community Health Systems, Inc.

(CYH) delivered a total return of -81. 0%, compared to -97. 8% for Nutex Health, Inc. (NUTX). Over 10 years, the gap is even starker: CYH returned -80. 3% versus NUTX's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NUTX or CYH?

By beta (market sensitivity over 5 years), Community Health Systems, Inc.

(CYH) is the lower-risk stock at 1. 60β versus Nutex Health, Inc. 's 2. 01β — meaning NUTX is approximately 26% more volatile than CYH relative to the S&P 500.

05

Which is growing faster — NUTX or CYH?

By revenue growth (latest reported year), Nutex Health, Inc.

(NUTX) is pulling ahead at 82. 4% versus -1. 2% for Community Health Systems, Inc. (CYH). On earnings-per-share growth, the picture is similar: Community Health Systems, Inc. grew EPS 196. 7% year-over-year, compared to 7. 9% for Nutex Health, Inc.. Over a 3-year CAGR, NUTX leads at 58. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NUTX or CYH?

Nutex Health, Inc.

(NUTX) is the more profitable company, earning 8. 1% net margin versus 4. 1% for Community Health Systems, Inc. — meaning it keeps 8. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NUTX leads at 31. 5% versus -79. 4% for CYH. At the gross margin level — before operating expenses — NUTX leads at 50. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NUTX or CYH more undervalued right now?

Analyst consensus price targets imply the most upside for NUTX: 52.

3% to $205. 00.

08

Which pays a better dividend — NUTX or CYH?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is NUTX or CYH better for a retirement portfolio?

For long-horizon retirement investors, Community Health Systems, Inc.

(CYH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Nutex Health, Inc. (NUTX) carries a higher beta of 2. 01 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CYH: -80. 3%, NUTX: -97. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NUTX and CYH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NUTX is a small-cap high-growth stock; CYH is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

NUTX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 6%
Run This Screen
Stocks Like

CYH

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 142%
  • Gross Margin > 32%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NUTX and CYH on the metrics below

Revenue Growth>
%
(NUTX: 2.2% · CYH: 284.9%)
P/E Ratio<
x
(NUTX: 12.8x · CYH: 0.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.